COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,426,761 | -12.1% | 1,183,626 | +0.3% | 0.10% | -7.9% |
| Q2 2023 | $5,037,255 | -36.8% | 1,179,685 | +1.2% | 0.11% | -44.4% |
| Q1 2023 | $7,972,102 | -12.0% | 1,165,512 | +1.9% | 0.20% | -11.6% |
| Q4 2022 | $9,055,886 | -16.8% | 1,143,420 | +1.0% | 0.23% | -23.2% |
| Q3 2022 | $10,879,000 | +510.8% | 1,132,096 | +360.2% | 0.30% | +529.2% |
| Q2 2022 | $1,781,000 | -43.7% | 246,021 | +0.4% | 0.05% | -30.4% |
| Q1 2022 | $3,162,000 | -16.1% | 244,921 | +3.8% | 0.07% | -9.2% |
| Q4 2021 | $3,768,000 | -48.4% | 236,066 | -48.1% | 0.08% | -47.6% |
| Q3 2021 | $7,303,000 | +16.2% | 454,424 | 0.0% | 0.14% | +20.8% |
| Q2 2021 | $6,285,000 | +5.2% | 454,424 | +11.1% | 0.12% | -0.8% |
| Q1 2021 | $5,973,000 | -25.0% | 408,843 | -10.8% | 0.12% | -21.4% |
| Q4 2020 | $7,968,000 | -8.0% | 458,443 | -2.9% | 0.15% | -24.1% |
| Q3 2020 | $8,660,000 | – | 472,214 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |